Search tips
Search criteria 


Logo of ijpharsciHomeCurrent issueInstructionsArchives
Indian J Pharm Sci. 2010 Jan-Feb; 72(1): 18–23.
PMCID: PMC2883222

Development and Evaluation of pH-Dependent Micro Beads for Colon Targeting


The purpose of this research was to develop and evaluate multiparticulates of alginate and chitosan hydrogel beads exploiting pH sensitive property for colon-targeted delivery of theophylline. Alginate and chitosan beads were prepared by ionotropic gelation method followed by enteric coating with Eudragit S100. All formulations were evaluated for particle size, encapsulation efficiency, swellability and in vitro drug release.In vitro dissolution studies performed following pH progression method demonstrated that the drug release from coated beads depends on coat weights applied and pH of dissolution media. Mechanism of drug release was found to be swelling and erosion-dependent. The studies showed that formulated alginate and chitosan beads can be used effectively for the delivery of drug to colon and a coat weight of 20% weight gain was sufficient to impart an excellent gastro resistant property to the beads for effective release of drug at higher pH values.

Keywords: Alginate, chitosan, colon targeting, Eudragit S100, multiparticulates, theophylline

There has been a considerable research for design of colonic drug delivery system. Colon targeting has been achieved by several ways, which include prodrugs, pH- and time-dependent systems. Polysaccharides such as chitosan, pectin, inulin, alginate, guar gum have been explored for their potential for colon specific drug delivery. To achieve successful colon drug delivery, a drug needs to be protected from degradation, release and/or absorption in upper portion of GI tract and then ensure abrupt or controlled release in proximal colon. Colon targeting is usually advised because of advantages i.e, reduced dosing frequency; achieve high concentration at distal gut for local treatment; chronotherapy and delivery of drug to a region that is less hostile metabolically[1].

Multiparticulates offer greater advantages over single unit system as they disperse uniformly in GI tract, offer flexibility and less inter and intra individual variability in formulation process. Multiparticulates present several advantages in comparison to single unit forms that they exhibit higher colonic residence time and more predictable gastric emptying[2].

Alginate is linear, naturally occurring polysaccharide extracted from brown sea algae. In presence of various divalent (Ca2+ and Zn2+) or trivalent ions (Al3+), an elastic gel is formed due to ionic interaction between the ions and carboxyl group, mainly of guluronic blocks. Chitosan, a naturally occurring polysaccharide has received major attention in drug delivery system. It is biocompatible and non toxic. Chitosan is weak cationic polysaccharide composed of (a (1→4) 2-amino-2deoxy-β-D-glucan) obtained by alkaline deacetylaion of chitin[3].

Asthma is a chronic obstructive lung disease characterized by airways inflammation and hyper reactivity. In most patients, conditions worsen at night with acute exacerbation being in most common[4]. Clinical and epidemiological studies suggest that asthma is several hundred folds more likely at night than during day with disturbance of sleep. The heightened risk of asthma at night coincides with the trough of circadian rhythm. A colonic drug delivery system would be valuable when a delay in absorption of drug is therapeutically desirable in treatment of chronic conditions like nocturnal asthma, which coincides with trough of circadian rhythm[5].

The physiological changes in pH of gastrointestinal tract have been extensively exploited to target the actives moieties to colon. Methods based on pH sensitive delivery such as delayed onset dosage forms could be a simple and practical means for colon targeting. Polymer particularly Eudragit S100 have been investigated for colonic delivery. Since the pH of colon in normal subjects varies from 6.4±0.6 to 7.5±0.4, these polymers have been designed to be soluble at pH >7[6].

The aim of present investigation was to work out feasibility of combination of multiparticulates and pan coating to produce pH sensitive micro beads of theophylline for colon targeting. The major objective was to modulate drug release from these coated multiparticulates to specifically target the nocturnal peak symptoms of asthma.


Theophylline hydrochloride (TH) was a gift sample from French Pharma, Chandigarh, India. Chitosan (CH) and sodium alginate were purchased from Sigma Aldrich Chemicals, Bangalore, India. Triethyl citrate was purchased from Himedia laboratories Pvt. Ltd, Mumbai. Ethylcellulose (EC) was purchased from S. D. Fine-Chem Limited, Mumbai, India. Eudragit S100 was a gift sample from Cadila, Ahmedabad, India. All other chemicals used were of analytical reagent grade.

Preparation of drug loaded beads:

Alginate, chitosan beads containing theophylline was prepared by ionotropic gelation method. Theophylline was dispersed in sodium alginate (2% w/v) solution or chitosan (3% w/v) solution in suitable solvents (Table 1). The drug-polymer dispersion was dropped through a needle (#20) into agitated 5% w/v aqueous calcium chloride solution (100 ml) and 2% w/v aqueous solution of tripolyphosphate (pH adjusted to 5), respectively for alginate and chitosan. Beads were left for 30 min, and washed twice with distilled water and dried at 50° for 4 h and then at room temperature (25°) for 2 days for complete drying[79].


Polymer reinforced beads:

Theophylline was dispersed uniformly in sodium alginate (2% w/v) solution and ethylcellulose (2% w/v) was mixed and stirred for 30 min and then drop wise added to agitated 5% w/v calcium chloride solution (100 ml). Chitosan reinforced alginate beads were prepared by dispersing theophylline in sodium alginate solution (2% w/v). The solution was dropped through a needle (#20) into agitated 5% calcium chloride solutions (100 ml) with chitosan (0.5% w/v) already dissolved in acetic acid solution (1% v/v). Beads were left for 30 min, and washed twice with distilled water and dried at 50° for 4 h and then at room temperature (25°) for 2 days for complete drying[10,11].

Coating of beads:

The enteric coating of all the beads bearing theophylline was performed by spray coating in a conventional coating pan. In brief coating solution was prepared by mixing Eudragit S100 with acetone for 1 h using a stirrer. After an hour, triethyl citrate (TEC) 6% w/v was added and stirring was continued for 30 min. Coating was done with a pan rotating at 20 rpm, with an inlet air temperature 60 to 70° and outlet air temperature of 35 to 40°. The solution was sprayed at an atomizing air pressure of 2 bars. The coating was continued until the desired weight gain was achieved. A series of coated products with different film thickness were produced, quantified by the total weight gain (%TWG), by varying amount of coating solution sprayed[12].

Particle size analysis:

The particle size of prepared beads was measured with an optical microscope fitted with a calibrated eyepiece. The mean of 50 beads was noted as particle size. To determine the particle size of ethyl cellulose reinforced alginate beads dial thickness meter was used.

Drug content and encapsulation efficiency:

The theophylline in the beads was determined by digesting the beads in PBS (pH 7.4) and 0.1 N HCl (pH 1.2), respectively, for sodium alginate and chitosan beads. The extracted drug concentration was determined spectrophotometrically (UV-1601, Shimadzu, Japan) at 272 nm for alginate beads and 269 nm for chitosan beads. The encapsulation efficiency of prepared hydrogel beads was calculated in terms of ratio of drug in formulation to amount of drug added[5].

Swelling studies:

Swelling studies for coated beads was performed in three different media simulating transition of beads in GIT (pH 1.2, 6.8 and 7.4). Swelling index was calculated from the formula: Swelling index= (Wg–Wo)/Wo×100, where Wo is the initial weight of beads and Wg is the weight of beads in the swelling medium[1214].

In vitro drug release studies:

In vitro drug release studies were performed using USP dissolution test apparatus (Apparatus 2). The dissolution studies were performed in 900 ml of dissolution medium, which was stirred at 100 rpm at 37±0.1° following a pH progression method i.e pH 1.2 for first 2 h, pH 6.8 for next 3 h and pH 7.4 for rest of studies. Aliquots was withdrawn periodically and replaced with fresh medium. Theophylline content in the aliquots was assayed spectrophotometrically (UV-1601, Shimadzu, Japan) at 269 nm for pH 1.2 and 272 nm for the rest of the samples[15].


Alginate and chitosan beads were prepared by dropping the solution of the drug alginate dispersion into calcium chloride solution, and for drug-chitosan-dispersion into tripolyphosphate solution, where beads were formed due to cross linking of alginate by calcium ions, and for chitosan with phosphoric ions. Preparation of beads by ionotropic gelation is based on the ability of various polysaccharides such as pectin, alginate, chitosan, and gellan to form a gel in the presence of multivalent ions. Beads can therefore be prepared simply by adding, drop wise, a dispersion of polysaccharide and material to be encapsulated into solution of multivalent ions. The contact of droplets with the ions results in instantaneous formation of spherical gel structures containing the material to be encapsulated uniformly dispersed throughout the polysaccharide matrix.

Alginate and chitosan micro beads were successfully prepared by ionotropic gelation method. The beads were coated with Eudragit S100 by spray coating in a conventional coating pan. The coated beads were found to be of spherical shape. Diameter of beads varies as shown in Table 2 for different formulations. The result indicates that as the amount of polymer (alginate and chitosan) increases, the size of beads proportionally increases.


Moreover, longer the cross linking time, lower the size of beads. The bead diameter decreased as the cross linking time was increased, because there is greater time for the cross linker to promote formation of cross links with chitosan molecules or alginate molecules and make a more compact mass. The longer the hardening time, the smoother and more spherical were the beads obtained. Coating thickness over drug bearing beads was obtained in terms of total weight gain (TWG) of beads after enteric coating with Eudragit S100 dispersion and their effect on in vitro drug release in simulated GI fluid was studied.

The effect of various formulations parameters on entrapment efficiency of prepared hydrogel beads are shown in Table 2. The entrapment efficiency of prepared beads varied from 63.77±1.41 to 81.58±1.81% for alginate beads and for chitosan beads it varies from 55.21±1.5 to 79.60±1.43%. Entrapment efficiency and drug content increased significantly with increasing polymer concentration (alginate or chitosan) as shown in Table 2. This is because the increase in polymer concentration resulted in formation of larger beads entrapping more drug. This result is well correlated with similar result reported earlier for alginate-chitosan beads of timolol maleate[16].

Swelling studies for coated beads was performed in three different pH (1.2, 6.8 and 7.4) simulating transition of beads in GIT. Swelling studies carried out shows that maximum swelling for all batches of beads is in simulated intestinal fluid (pH 7.4) as shown in figs. figs.11 to to4.4. The swelling of calcium alginate beads in phosphate buffer is related to Ca2+ and Na+ exchange. In initial phase Na+ ions present in phosphate buffer exchange with Ca2+ ions, bound to COO- groups of mannuronic blocks. As a result, an electrostatic repulsion between negatively charged COO- groups increases resulting in gel swelling. Exchanged Ca2+ ions precipitate in the form of insoluble calcium phosphate reflecting in slight turbidity of swelling medium. In the later phase of swelling, diffusion of Ca2+ from polyguluronate blocks cause loosening of tight egg-box structure and thus permit the penetration of additional amounts of media into the beads[17].

Fig. 1
Swelling profile of alginate beads with Eudragit S100 coating (10% weight gain)
Fig. 4
Swelling profile of Alginate beads with Eudragit S100 coating TWG 20%
Fig. 2
Swelling profile of Alginate beads with Eudragit S100 coating TWG 20%
Fig. 3
Swelling profile of Chitosan beads with Eudragit S100 coating TWG 10%

In case of chitosan beads, ionization of amine group on chitosan decreases with increasing pH proceeding to weaker cross linking density. At higher pH open porous structure with low density were also reported[18]. In case of ethylcellulose reinforced alginate beads the swelling was found to be to a lesser extent which is due to the hydrophobic nature of ethylcellulose.

In case of uncoated beads, nearly >70% of drug was released in initial 4 h of dissolution study. This situation is not acceptable for the drugs that are required to be released in colon. Therefore beads were coated with Eudragit S100 polymer to retard the release of drug until the pH reaches above 7.0.

In vitro release studies were carried out in order to evaluate effect of Eudragit S100 coat with an objective to release most of drug in the colon. The initial release of TH from coated hydrogel beads was low. However, some part of drug (10 to 15%) was released in initial 2 h from the beads having TWG 10%. In case of TWG 20%, very less amount of drug was found to be released (3 to 4%) which is less as compared to drug release from TWG 10%. Figs. Figs.55 to to88 show the drug release from various formulations in different simulated GI fluids.

Fig. 5
In vitro release profile of Alginate beads with Eudragit S100 coating TWG 10%
Fig. 8
In vitro release profile of Chitosan beads with Eudragit S100 coating TWG 10%
Fig. 6
In vitro release profile of Alginate beads with Eudragit S100 coating TWG 20%
Fig. 7
In vitro release profile of Chitosan beads with Eudragit S100 coating TWG 10%

In case of alginate beads (A1, A2, A3, A4, A5) having a coat of TWG 10%, at the end of 5 h the release was found to be 26.25±1.09, 6.80±1.81, 10.58±1.29, 11.07±1.59 and 6.07±2.35%, respectively. In case of beads having a coat of TWG 20%, Eudragit S100 coat release at end of 5 h was found to be 7.18±1.19, 4.51±1.23, 3.29±1.15, 4.23±1.29 and 2.66±1.89%, respectively. For chitosan beads (C1, C2, C3 and C4) having a coat of TWG 10% Eudragit S100 coat, release at end of 5 h was found to be 26.68±1.33, 18.06±1.28, 13.25±1.17 and 6.28±1.09%, respectively. In case of beads having a coat of TWG 20% Eudragit S100 coat release at the end of 5 h was found to be 3.59±1.63, 1.27±1.09, 6.73±1.13 and 2.54±1.47%, respectively.

However, >80% of drug was released when pH was gradually raised above 7.0. The result indicates that drug was protected completely from upper GIT condition by a coating of Eudragit S100, because Eudragit polymer contain carboxyl group that ionize in an environment where pH is greater then 7. As ionization take place, integrity of film was disturbed and drug is released. At pH 7.4, membrane coating get dissolved and beads were exposed to dissolution media following which the polymer matrix swells and erodes releasing entrapped drug.

Drug release data was plotted according to first order, Higuchi's and Korsemeyer-Peppas equation to know the release mechanisms. The formulations showed linearity with respect to first order (R2 = 0.8471–0.9591) as compared to zero order (R2 = 0.7022–0.8560) for formulations having TWG 10% coat thickness. Formulations having TWG 20% coat thickness also showed the linearity with respect to first order (R2 = 0.8833–0.9545) as compared to zero order (R2 = 0.7188–0.8090). Higuchi's equations for formulation having TWG 10% coat thickness ranges from (R2 = 0.7101–0.8278) and for formulation having TWG 20% coat thickness ranges from (R2 = 0.71936–0.7879) hence to confirm precisely the domination mechanism, the data was plotted according to Korsemeyer's equation. The resultant ‘n’ values was >1, for the all coated beads, indicating the super-case II transport mechanism.

Results of release studies indicate that Eudragit S100 coated hydrogel beads offer a high degree of protection from premature drug release in simulated upper GIT conditions. A well coat of Eudragit S100 delivers almost intact beads to colon[19], an environment rich in bacterial enzymes that degrade the polysaccharides and allow drug release to occur at desired site and can be a potential system for delivery of theophylline in cases of nocturnal asthma.


Khan et al.: pH-Dependent Microbeads of Theophylline


1. Rathbone JM, Jonathan H. Modified release drug delivery technology. 11th ed. New York: Marcel Dekker Inc; 2002.
2. Asghar ALF, Chandran S. Mulltiparticulate formulation approach to colon specific drug delivery: Current perspectives. J Pharm Pharm Sci. 2006;9:327–38. [PubMed]
3. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;224:19–38. [PubMed]
4. Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Del Rev. 2007;59:852–82. [PubMed]
5. Shivakumar HN, Suresh S, Desai BG. Design and evaluation of pH sensitive minitablets for chronotherapeutic delivery of theophylline. Indian J Pharm Sci. 2007;69:73–9.
6. Mastiholimath VS, Dandagi PM, Jain SS, Gadad AP, Kulkarni AR. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm. 2007;328:49–56. [PubMed]
7. Fatah EA, Grant A, Gabr KE. Physical characterstics and release behaviour of salbutamol sulfate beads prepared with ionic polysaccharides. Drug Develop Ind Pharm. 1998;24:541–7. [PubMed]
8. Bodmeir R, Oh KH, Parmar Y. Preparation and evaluation of drug containing chitosan beads. Drug Develop Ind Pharm. 1989;15:1475–94.
9. Manjunatha KM, Ramana MV, Satyanarayna D. Design and evaluation of diclofenac sodium controlled drug delivery systems. Indian J Pharm Sci. 2007;69:384–9.
10. Amitava G, Nath LK, Dey BK, Partha R. A study on effect of different polymers on frusemide loaded calcium alginate micropellets prepared by ionotropic gelation technique. Indian J Pharm Educ Res. 2007;41:329–36.
11. Rodriguez ML, Holgado MA, Lafuente SC, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm. 2002;232:225–34. [PubMed]
12. Jain SK, Jain A, Gupta Y, Ahirwar M. Design and development of hydrogel beads for targeted drug delivery to the colon. AAPS PharmaSciTech. 2007;8:E1–8. [PMC free article] [PubMed]
13. Paspatakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm. 2006;323:34–42. [PubMed]
14. Smrdel P, Bogataj M, Zajc N, Mazaj M, Mrhar A. Characterization of calcium alginate beads containing structurally similar drugs. Drug Develop Ind Pharm. 2006;32:623–33. [PubMed]
15. Emma L, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanism for colonic targeting in man. J Control Rel. 2008;130:154–60. [PubMed]
16. Sezer AD, Akbuga J. Release characterstics of chitosan treated alginate beads. I. sustained release of low molecular drug from chitosan treated alginate beads. J Microencapsul. 1999;19:195–203. [PubMed]
17. Smrdel P, Bogtaj M, Zega A, Planinsek O, Mrhar A. Shape optimization and characterization of polysaccharides beads prepared by ionotropic gelation. J Microencapsul. 2008;25:90–105. [PubMed]
18. Srinatha A, Pandit JK, Singh S. Ionic cross linked chitosan beads for extended release of ciprofloxacin: in vitro characterization. Indian J Pharm Sci. 2008;70:16–21. [PMC free article] [PubMed]
19. Ganesan M, Rajan MG, Prabhu RS, Deattu N. Preparation and evaluation of delayed release multiparticles of flurbiprofen. Indian J Pharm Sci. 2000;62:136–9.

Articles from Indian Journal of Pharmaceutical Sciences are provided here courtesy of Medknow Publications